Bellicum Pharmaceuticals, Inc. (BLCM): Price and Financial Metrics
BLCM Price/Volume Stats
| Current price | $0.07 | 52-week high | $1.31 |
| Prev. close | $0.08 | 52-week low | $0.06 |
| Day low | $0.07 | Volume | 6,000 |
| Day high | $0.09 | Avg. volume | 22,874 |
| 50-day MA | $0.11 | Dividend yield | N/A |
| 200-day MA | $0.29 | Market Cap | 726.83K |
BLCM Stock Price Chart Interactive Chart >
Bellicum Pharmaceuticals, Inc. (BLCM) Company Bio
Bellicum Pharmaceuticals is a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies for various forms of cancer, including hematological cancers and solid tumors, as well as orphan inherited blood disorders. The company was founded in 2004 and is based in Houston, Texas.
BLCM Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
BLCM Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -93.14% |
| 5-year | -99.20% |
| YTD | N/A |
| 2024 | 0.00% |
| 2023 | -79.17% |
| 2022 | -51.68% |
| 2021 | -57.79% |
| 2020 | 173.64% |